Table of contents
In response to growing concerns around supply chain disruption, the FDA has issued a set of exemptions for the final requirements of the U.S. Drug Supply Chain Security Act (DSCSA).
If you’re wondering how these exemptions will impact your business, watch our recent Q&A! Your peers joined us live to ask TraceLink’s DSCSA experts pressing questions like:
- What are the specific exemptions?
- What is the definition of an eligible trade partner?
- What steps should be executed to meet the deadlines?
Our DSCSA experts have worked with hundreds of companies, and have insight into navigating many of the roadblocks companies encounter on the path to DSCSA compliance. Watch this Q&A and get the answers you need to guide your preparations.
Speakers
Dan Walles
General Manager of Traceability & Compliance, TraceLink
Shrijan Rajkarnikar
Sr. Manager, Center of Excellence, TraceLink